Dr. Spiros Liras,
Vice President of WorldWide Medicinal Chemistry
Pfizer, Inc.

“Phosphodiesterase Inhibitors for the Treatment of Neuropsychiatric Disorders”

When: Thursday, October 8th, 2015
4:30-5:30PM: Seminar
5:30-7:00PM: Networking reception
Where: The Texas Union, Santa Rita Suite, UNB 3.502
SE corner of 24th and Guadalupe (2308 Whitis Ave), Austin, TX 78713

RSVP and more information available here.

Bio: Spiros Liras is Vice President, WorldWide Medicinal Chemistry at Pfizer. He is the head of Cardiovascular, Metabolic and Endocrine diseases medicinal chemistry, a position he has held since 2008. Prior to this appointment, Dr. Liras was Senior Director of Neuroscience medicinal chemistry where he worked in the areas of addiction, schizophrenia and neurodegenerative disorders. Dr. Liras joined Pfizer in 1994 after a postdoctoral appointment in organic synthesis at the University of Texas at Austin under the direction of Professor Stephen Martin.

This event is open to both the UT Austin and Central Texas life sciences and biotechnology communities. We invite anyone interested in the intersection of life sciences research and pharmaceutical advancement to attend.